- Services Overview
- Biorepository/Biobanking Overview
- Cell Therapy Services
- Laboratory Overview
- Storage/Transport of Bio-API
- Kit Production/Clinical Trial Support
- Qualification / Validation Services
- News/Press Releases
As featured on Genetic Engineering & Biotechnology News (GEN)- "Technology Evovling for Cellular Therapies", Fisher BioServices is equipped to provide storage and cold chain transportation capabilities for the entire spectrum of cell-based and regenerative medicine worldwide. We provide distribution of cell-based therapies from manufacturer to patient bedside, with complete chain of custody.
We have years of experience in cryogenic storage and cold chain transport of cryopreserved research and clinical-grade biologics. We provide biobanking of master and working cell banks and intermediate materials. We transport and store biological active pharmaceutical ingredient (bio-API).
We start small, partnering with you in phase I activities, and staying with you as your needs grow through phase III, licensure, and global commercial distribution. Our repository and distribution operations are scalable and flexible.
We can design and assemble kits for the collection of autologous and allogeneic specimens, as well as supplies for the freezing and storage of manufactured product and ancillary samples (such as for stability studies).
To learn more about cell therapy logistics and ultra cold chain distribution in clinical commercial development, check out our eBook on "Commercially Successful Cell Therapies" or click here to read our brochure about our cell therapy services.